Adienne
Skip to content
  • Home Page
  • About
    • Management
    • Manufacturing
  • Products
    • TEPADINA®
      • Canadian Product Monograph
  • R&D
    • Antibodies
    • Recombinant Proteins
    • Molecules in Development
      • ADN-MCL
      • ADN-LYS
      • Begelomab
      • MUBODINA®
  • MEDIA
  • Contact Us
    • Locations
    • For Medical Inquiries
    • To Notify Side Effects
  • Careers

ADIENNE Pharma & Biotech announces FDA Approval of TEPADINA

Posted on 25 February 2019 by admin

This entry was posted in PressRelease. Bookmark the permalink.

Post navigation

← ADIENNE Pharma & Biotech Receives FDA’s Drug Shortage Assistance Award
ADIENNE Pharma & Biotech annuncia l’approvazione di TEPADINA da parte di FDA →
Cookie Policy
Privacy Policy
Zelle Lite Developed by ThemeIsle

This website uses cookies to provide you with the best browsing experience.

Find out more or adjust your settings.

Adienne
Panoramica privacy

Questo sito Web utilizza i cookie per consentirci di offrire la migliore esperienza utente possibile. Le informazioni sui cookie sono memorizzate nel tuo browser ed eseguono funzioni come riconoscerti quando ritorni sul nostro sito web.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

Cookie Policy

Altre informazioni riguardo la nostra Cookie Policy